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ABSTRACT Exposing bovine lipid extract surfactant (BLES), a clinical surfactant, to reactive oxygen species arising from
hypochlorous acid or the Fenton reaction resulted in an increase in lipid (conjugated dienes, lipid aldehydes) and protein
(carbonyls) oxidation products and a reduction in surface activity. Experimentswhere oxidized phospholipids (PL) weremixedwith
BLESdemonstrated that this addition hamperedBLESbiophysical activity. However the effects were onlymoderately greater than
with control PL. These results imply a critical role for protein oxidation. BLES oxidation by either method resulted in alterations in
surfactant proteins SP-B and SP-C, as evidenced by altered Coomassie blue and silver staining. Western blot analyses showed
depressed reactivity with speciﬁc antibodies. Oxidized SP-C showed decreased palmitoylation. Reconstitution experiments
employing PL, SP-B, and SP-C isolated from control or oxidized BLES demonstrated that protein oxidation was more deleterious
than lipid oxidation. Furthermore, addition of control SP-B can improve samples containing oxidized SP-C, but not vice versa. We
conclude that surfactant oxidation arising from reactive oxygen species generated by air pollution or leukocytes interferes with
surfactant function through oxidation of surfactant PL and proteins, but that protein oxidation, in particular SP-B modiﬁcation,
produces the major deleterious effects.
INTRODUCTION
Pulmonary surfactant is a complex mixture of lipids and
proteins essential for normal lung function. Surfactant forms
a ﬁlm at the alveolar air-water interface that reduces the
surface tension (g), thereby reducing the work of breathing,
protecting the alveoli against collapse at end-expiration, and
reducing transudation of ﬂuid from interstitial spaces (1–3).
In addition to its surface-active properties, surfactant func-
tions in the lung’s host defense system and as an inﬂamma-
tory reducing agent (4,5).
Surfactant chemical composition is conserved among
most mammalian species, consisting of ;80–90% phospho-
lipids (PL), ;2–10% neutral lipids, and ;10% surfactant-
associated proteins SP-A, SP-B, SP-C, and SP-D. The major
surfactant PL is dipalmitoyl-phosphatidylcholine (DPPC;
35–40%), and, depending on the species, unsaturated PLs
represent 50–60% of the weight of mammalian surfactants
(6,7). The high proportion of DPPC is thought necessary for
surfactant to be able to achieve gs near zero mN/m during the
ﬁlm compression occurring at expiration. In addition, it ap-
pears that surfactant needs unsaturated lipids to act as
liqueﬁers for efﬁcient adsorption to form a surface active ﬁlm
and for reinsertion of material during expansion of the ﬁlm
during the breathing cycle (3,7,8).
SP-A and SP-D belong to the collectin superfamily. SP-D
locates primarily in the aqueous compartment of the epithe-
lial lining layer, whereas SP-A is intimately associated with
surfactant lipid aggregates such as lamellar bodies, vesicles,
and tubular myelin (4,5). SP-A and SP-D have numerous
roles in the lung’s ﬁrst-line host defense system. Both bind to
a variety of pathogens, including bacteria, viruses, fungi, and
yeasts, as well as lipopolysaccharides and allergens, and these
proteins can modulate the production of reactive oxygen and
nitrogen species (4,5).
SP-B, a sulphydryl-dependent homodimer of two 8.5-kDa
monomers, is a membrane-associated protein, whereas SP-C
(4.2 kDa) is a palmitoylated hydrophobic protein terminating
in a C-terminal helix that functions as a transmembrane
segment (9). SP-B and SP-C promote the adsorption of sur-
factant lipids to the air-liquid interface and stabilize the sur-
factant ﬁlm during surface area reduction allowing it to attain
gmins near zero mN/m. In addition, these hydrophobic pro-
teins increase respreading of PL from collapse phase thereby
allowing ﬁlms to maintain g near equilibrium during ex-
pansion (1–3,8–11).
Oxidative stress in the lung arises from environmental
exposure to air pollutants and cigarette smoke and can also
be a result of inﬂammation (12–14). Surfactant oxidative
modiﬁcations and dysfunction likely play a central role in the
pathogenesis of lung diseases, such as acute lung injury and
acute respiratory distress syndrome (ARDS) (2,15). Numer-
ous studies have conﬁrmed that patients with ARDS show
clear evidence of increased oxidative damage to lipids and
proteins, as well as biophysical alterations of lung surfactant.
For example, oxidative modiﬁcations of SP-A have been
found in bronchoalveolar lavage of ARDS patients (16).
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Surfactant large aggregates isolated from ARDS patients
exhibit high gmins relative to surfactant from controls (15).
Studies by various groups, including our own, have
reported that exposure of natural, modiﬁed natural (clinical),
or artiﬁcial surfactants to oxidative conditions resulted in
decreased surface activity, including prolonged adsorption
times and elevated gmin and gmax (17–21; see Rodrı´guez-
Capote et al. for review (22)). The disruptive effects of
reactive oxygen species (ROS) on surfactant biophysical ac-
tivity have been usually attributed to alterations in surfactant
lipids (18,21,23). Evidence indicating ROS damage to sur-
factant proteins has also been reported (17,24).
Despite considerable attention, the precise manner by
which ROS affect surfactant PL and proteins, and which
oxidative effects predominate, must still be established. To
address these issues, we oxidized bovine lipid extract sur-
factant (BLES), a clinical surfactant containing all of the
surfactant PL and the hydrophobic surfactant proteins SP-B
and SP-C, with either hypochlorous acid or the Fenton re-
action. A variety of analytical techniques were used to dem-
onstrate biochemical modiﬁcations in both surfactant PL and
hydrophobic proteins. Addition of oxidized phosphatidyl-
choline (PC) and phosphatidylglycerol (PG) molecular spe-
cies to BLES hampered surface activity, but the overall
effects were similar to those observed with control non-
oxidized lipids. Further studies demonstrate that oxidation
through either mechanism resulted in modiﬁcation of SP-B
and SP-C, resulting in alterations in the ability to interact
with either Coomassie blue or silver staining. Hydrophobic
protein interactions with speciﬁc antibodies were also af-
fected. These observations prompted reconstitution studies
using surfactant PL, SP-B, and SP-C isolated from control
and oxidized BLES, which demonstrated that both PL and
apoproteins are negatively inﬂuenced by oxidation. How-
ever, it became evident that the effects of ROS on the hy-
drophobic surfactant proteins have a greater inﬂuence on the
surface activity than those on PL. Furthermore, the results
indicate that oxidation of SP-B is more deleterious to sur-
factant function than oxidation of SP-C.
EXPERIMENTAL PROCEDURES
Reagents
All reagents were purchased from Sigma/Aldrich (Oakville, ON, Canada)
and/or VWR Canlab (Mississauga, ON, Canada) unless otherwise noted.
BLES was a kind gift of BLES Biochemicals (London, ON, Canada).
Whatmann LK5 thin-layer plates with a concentration zone were employed
for thin-layer chromatography (TLC).
DPPC was purchased from Sigma. 1-Palmitoyl-2-hydroxy-sn-glycero-
3-phosphocholine (LPC), 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-
rac-(1-glycerol)] sodium salt (LPG), 1-palmitoyl-2-oleoyl-sn-glycero-3
phospho-rac-(1-glycerol)-sodium salt (POPG), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC), 1-palmitoyl-2-linoleoyl-sn-glycero-3-
phosphocholine (PLPC), 1-palmitoyl-2-linoleoyl-sn-glycero-3-[phospho-
rac-(1-glycerol)] sodium salt (PLPG), 1,2-diarachidonoyl-sn-glycero-3-
phosphocholine (AAPC), and 1,2-diarachidonoyl-sn-glycero-3-[phospho-
rac-(1-glycerol)] sodium salt (AAPG) were obtained from Avanti Polar
Lipids (Birmingham, AL).
Hypochlorous acid was purchased as sodium hypochlorite (NaOCl) from
Sigma/Aldrich, speciﬁed with an active chlorine content of 10–13%. The
hypochlorite concentration was determined spectrophotometrically imme-
diately before use by diluting the NaOCl stock solution 1:10 in 1 MNaOH at
240 nm using a molar extinction coefﬁcient for pH 12 of 43.6 mol1 cm1.
In vitro oxidation
For all oxidative treatments the reaction mixtures composed of 10 mg/ml
surfactant lipids, plus Fenton reagents, hypochlorous acid, or controls in
working buffer (in mM: 150 NaCl, 2 Tris-HCl, and 1.5 CaCl2 at pH 7.4),
were incubated at 37C in a shaking water bath for 24 h. Oxidation was
halted by extraction with chloroform/methanol. For oxidation by the Fenton-
like chemistry, BLES at 10 mg/ml was incubated with 0.65 mM FeCl2, 0.65
mM sodium ethylenediamine tetraacetic acid (EDTA), and 30 mM H2O2 in
working buffer at a pH of 7.4 for 24 h (17,20). Fenton controls consisted of
BLES in working buffer incubated with FeCl2/EDTA, H2O2, or alone.
Treatment with HOCl/OCl was carried out at a ﬁnal concentration of
0.5 mM at pH 7.4 in working buffer (17,20).
Because the oxidizing conditions could theoretically affect measurement
of lipid and/or protein concentrations, the PL and protein concentrations of
triplicate surfactant samples were examined before and after oxidation, using
the phosphorus assay (25) and the Lowry method (26,27), respectively.
Total PL concentrations of hypochlorous-treated BLES (H;BLES) and
Fenton-treated BLES (F;BLES) were 100.7 6 1.5% and 102.1 6 1.3%,
respectively, of control BLES (C;BLES). Resultant protein concentrations
were 109.66 0.4% for H;BLES and 112.36 1.3% for F;BLES relative to
C;BLES. Neither PL nor protein concentrations were markedly inﬂuenced
by the oxidative reactions; consequently, phosphorus estimations and Lowry
protein levels were used to control the concentrations of whole BLES and
reconstituted surfactants for surface activity measurements and biochemical
analyses.
Phospholipid analyses
Lipid peroxidation
For primary lipoperoxidation products, conjugated dienes formed during
oxidation were measured on diluted aliquots via spectrophotometric moni-
toring of the absorbance at 235 nm (A235) after exposure to HOCl/
OCl or
Fenton reagents, as above. Aliquots of the control or oxidized BLES were
diluted to 0.25 mg/ml of surfactant using working buffer. A235 was deter-
mined every 10 min for 5.5 h against a buffer blank.
For secondary lipoperoxidation products, the degree of lipid peroxidation
during oxidation was determined by measuring the amounts of the secondary
products malondialdehyde (MDA) and 4-hydroxynonenal (4HNE), using the
lipid peroxidation assay kit BIOXYTECH (OXIS International) according to
the manufacturer’s instructions.
Thin layer chromatography
The PL samples in chloroform/methanol (1:1) were applied 20–200 mg in
the concentration zone as 1-cm parallel streaks. Commercial phospholipids
were used as standards. Plates developed with mobile phase consisting of
chloroform/ethanol/water/triethylamine (30:35:7:35, v/v) (28). Individual
PL subtypes were visualized either by molybdenum blue spray reagent
(Sigma-Aldrich) or by the ﬂuorescence dye primuline (0.05 mg/ml) (Sigma-
Aldrich) dissolved in acetone:water (80:20, v/v) under low ultraviolet illu-
mination. Fluorescent spots were scraped into glass tubes and the total PL
content was determined by inorganic phosphate assay (25,28). The amount
of phospholipids was calculated by multiplying the amount of Pi by 25.
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Protein analyses
Protein isolation
Pulmonary SP-B and SP-C were isolated from BLES (BLES Biochemicals)
by LH-60 chromatography as previously described (27,29). Protein con-
centrations were determined by a modiﬁcation of the method of Lowry et al.
(26,27). Correction factors of 2.0 for SP-B and 3.0 for SP-C relative to BSA
were adopted on the basis of amino acid analysis as indicated previously
(20,29,30). The purity of the proteins was routinely assessed by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using 18%
gels. After isolation, surfactant proteins and PL were stored as chloroform/
methanol: 0.1M HCl (1:1:0.05) solutions at -20C until required.
Protein carbonyl concentration was determined by enzyme-linked immu-
nosorbent assay (ELISA), using the Zentech PC Test Kit (Zenith Technology,
Dunedin, New Zealand).
SP-B ELISA measurements were conducted using a mouse monoclonal
antibody to human SP-B, kindly donated by Dr Y. Suzuki, Kyoto Uni-
versity, Japan, using the PL-soluble ELISA protocol developed by Kramer
et al. (31). SP-B in the samples was calculated in comparison to puriﬁed
bovine SP-B standard.
For SP-B western blot analysis, nonreduced samples (a total of 2 mg of
protein per lane) were separated on SDS-14.5% PAGE and subsequently
electroblotted onto hydrophobic polyvinylidene diﬂuoride membranes
(Immobilon-PSQ, Billerica, MA). SP-B was detected with a monoclonal
antibody against SP-B (kindly donated by Dr Y. Suzuki), by employing
enhanced chemiluminescence (SuperSignal West Femto from BioLynx, San
Antonio, TX) and Kodak Biomax XAR ﬁlm (Rochester, NY). This anti-
serum recognizes bovine, human, rabbit, and rat SP-B by western blotting
and does not cross-react with SP-A, SP-C, rat serum proteins, or BSA.
For SP-C western blot analyses, one-dimensional SDS-PAGE was per-
formed using Novex 10–20% tris-tricine gels (Invitrogen, Carlsbad, CA) at
70 V for 3 h. A total of 2 mg of protein (as determined by Lowry) was applied
per lane. The gels were silver-stained using a commercially available kit
(Bio-Rad, Rockville Center, NY). Separate (nonstained) gels were elec-
trophoretically transferred onto Immobilon-PSQ membranes and immuno-
blotted using a monospeciﬁc rabbit antiserum for SP-C as the primary
antibody (kind gift of Dr W. Steinhilber, Altana Pharma AG, Constance,
Germany). Immunoreactive bands were visualized by chemiluminescence
using Kodak Biomax XAR ﬁlm.
For SP-C palmitoylation levels, a modiﬁcation of the [14C] iodoaceta-
mide assay developed by Qanbar et al. (32,33) was employed. Control and
oxidized BLES and isolated SP-C from control and oxidized BLES (500 ng
of total protein each) were mixed with triethylamine (TEA, 3 M) and 150
nCi of [14C] iodoacetamide (Dupont/NEN, Boston, MA) in chloroform-
methanol (1:1), and the mixture (ﬁnal volume, 170 ml) was incubated for 3 h
at 37C. After separation of the proteins on Novex precast 10–20% gradient
Tricine gels, samples were transferred onto Immobilon-PSQ membranes.
The relative amount of mature SP-C was determined by quantitation of [14C]
SP-C bands with the software QuantiScan for Windows, BIOSOFT 99.
Captive bubble tensiometry
For the PL addition experiments, captive bubble tensiometer (CBT) assays
were performed in triplicate, using 50 mg/ml BLES or BLES:PL samples
dried under nitrogen and dispersed in working buffer. Adsorption, quasistatic,
and dynamic experiments were conducted as described previously (20,29).
Reconstituted samples were prepared by combining PL fractions from the
column with isolated oxidized/nonoxidized 1% by weight SP-B and/or SP-
C, also in organic solvent. This protein percent was adopted on the basis of
preliminary studies performed with 0.5, 0.75, 1, and 1.5% of protein to ﬁnd
the optimal PL:protein ratio. For these studies, the lipid-protein mixtures
were dried under a stream of nitrogen in Teﬂon tubes and then reconstituted
in working buffer to a ﬁnal concentration of 500 mg/ml. All samples were
vortexed and shaken in an incubator with glass beads at 37C for at least 1 h
before studies on surface activity were initiated (29).
Statistical analysis
All experiments were performed in duplicate at least three separate times
with individual freshly prepared samples. Statistical comparisons were con-
ducted using SPSS (Chicago, IL) software. Comparisons among the three
groups for the PL addition and the reconstitution studies were conducted by
analysis of variance (ANOVA) followed by Bonferroni and Tukey post-hoc
tests. Probability values ,0.05 are considered signiﬁcant.
RESULTS
Effects of free radical exposure on
surfactant phospholipids
Initial studies examined the effects of free radical exposure
on the lipid components of C;BLES, F;BLES, or H;BLES.
Conjugated diene formation was monitored during 5 h expo-
sure of surfactant to the free radical generating systems (Fig.
1 A). C;BLES (solid circles), BLES plus Fe12:EDTA (open
circles), or H2O2 (solid triangles) portrayed similar absorbance
FIGURE 1 Primary and secondary lipoperoxidation products. (A) The
conjugated dienes formed during oxidation were monitored at 235 nm for 5
h (n ¼ 3). Control samples are BLES in the absence of oxidants (C;BLES-
1, d); in the presence of H2O2 (C;BLES-3, s); and with Fe
21:EDTA
(C;BLES-2,;). Experimental samples included BLES in the presence of
HOCl/OCl (=) and complete Fenton reagents (n). (B) The presence of
secondary lipoperoxidation products was tested as the content of MDA and
4HNE by using the lipoperoxidation assay kit (BIOXYTECH). Compari-
sons between two groups were made using paired Student t-test (*, p, 0.05;
**, p , 0.001).
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readings at 235 nm, which increased slightly over the ﬁrst
60-min period and decreased slowly thereafter. When BLES
was exposed to the complete Fenton reagents (solid squares)
or to HOCl/OCl (open triangles), there was an immediate
increase in absorbance that reached a maximum around 60
min, after which it declined. Higher increases in A235 were
manifested with the Fenton reaction compared to hypochlo-
rous acid. The decrease in absorbance observed is consistent
with the further modiﬁcation of the conjugated dienes
generated from susceptible unsaturated fatty acids and the
production of secondary lipoperoxidation products such as
MDA and 4HNE, which do not absorb ultraviolet.
The presence of MDA and 4HNE was conﬁrmed by
analyzing the samples 24 h after reaction initiation. F;BLES
generated six times more MDA and HNE than its controls,
whereas H;BLES produced a fourfold increase over C;BLES.
These results (Fig. 1 B) are in overall agreement with the
kinetics of the conjugated diene formation reported in this
study and with previously published results reporting eleva-
tions in primary and secondary lipid peroxidation products
after incubation of various surfactants with in vitro free radi-
cal generating systems (17,19,20,34).
TLC was used to examine PL classes, in particular to es-
tablishwhether lysoPL, detected previously bymass spectrom-
etry (20), was formed during F; or H; oxidation. Samples
of BLES, oxidized BLES, and the PL fractions isolated by
LH-60 chromatography were fractionated by TLC and the
phosphorus content determined. Table 1 lists the amounts of
each PL recovered, expressed as a percentage of the total.
After 24 h of exposure to hypochlorous acid or the Fenton
reagents, the PC content decreased by;20%. The decreases
in PC were accompanied by increases in LPC.
Lung surfactant PG is richer in unsaturated fatty acids than
surfactant PC. PG percentage contents decreased by 35–
45%. This was usually associated with increases in percent-
age of LPG. It will be noted that the increases in LPC and
LPG do not account in full for the reduction in PC and PG.
Part of this deﬁcit likely arose from streaking of oxidized PL
on the TLC plates. This was clearly extenuated in the case of
the isolated PLs. Although there is no proof, we believe that
the increases in phosphatidylethanolamine (PE) and phos-
phatidylinositol (PI) observed with the isolated oxidized PLs
reﬂects streaking of oxidized lipids. In addition, part of the
decreased recoveries arose from the PL phosphorus remain-
ing at the origin with oxidized samples. These effects likely
obscured alterations in minor PL components such as PI
and PE. No differences were detected between Fenton- and
hypochlorous-reacted surfactants.
Effects of free radical exposure on
surfactant proteins
Protein carbonyls are the most commonly measured products
of protein oxidation in biological samples (52). Fig. 2 is a bar
graph summarizing protein carbonyls measured by ELISA.
Protein carbonyl concentration was increased in oxidized
BLES compared to C;BLES ( p , 0.01), with protein
carbonyls in F;BLES six times higher than H;BLES ( p ¼
0.008). Isolated SP-B and SP-C from oxidized BLES also
contained increased protein carbonyls when compared to
their controls ( p, 0.01). Differences between hypochlorous
reaction and Fenton were found only for isolated SP-B, where
the F;SP-B revealed 2.6 times more protein carbonyls than
H;SP-B.
Addition of unsaturated oxidized or nonoxidized
PL to BLES
The observation that both surfactant lipids and proteins are
modiﬁed during oxidation prompted investigations on the
effects of adding oxidized PL to BLES on biophysical ac-
tivity. For these experiments POPG, POPC, PLPC, PLPG,
AAPC, and AAPG were exposed to either the Fenton or
HOCl/OCl in vitro free radical generating systems as used
for BLES oxidation (20). After 24 h of incubation, control
and oxidized PL were extracted and added to BLES in
organic solvent (at 20% w/w). The surfactant mixtures were
TABLE 1 Effect of BLES oxidation on phospholipid classes
BLES H-BLES F-BLES PL H;PL F;PL
LPC 1.37 6 0.27 6.43 6 1.11** 5.03 6 0.76** 0.96 6 0.12 11.08 6 0.01** 9.19 6 0.063**
SM 1.81 6 0.35 1.89 6 0.31 1.93 6 0.40 1.59 6 0.00 2.45 6 0.03* 1.75 6 0.05
PC 79.76 6 2.82 60.97 6 2.17* 58.88 6 2.32** 72.30 6 1.98 49.50 6 3.19** 50.00 6 2.23**
PE 2.43 6 0.55 3.30 6 0.80 3.53 6 0.62 0.49 6 0.03 2.85 6 0.09* 6.27 6 0.21**
LPG 1.29 6 0.29 3.75 6 0.16** 4.03 6 0.77** 1.32 6 0.03 1.37 6 0.04 1.41 6 0.04
PI 1.04 6 0.29 0.38 6 0.16 0.35 6 0.31 2.37 6 0.19 3.55 6 0.12 3.37 6 0.03
PG 14.10 6 1.10 9.02 6 0.22** 8.28 6 0.26** 11.39 6 0.44 7.96 6 0.28* 6.27 6 0.13*
LBPA 1.68 6 0.16 2.25 6 0.06* 2.23 6 0.16* 1.51 6 0.49 0.67 6 0.00 2.05 6 0.10
origin 1.12 6 0.25 7.36 6 0.84* 9.60 6 0.65* 1.56 6 0.27 8.76 6 0.24* 8.39 6 0.48*
Control: H;BLES and F;BLES were extracted and the recovered PLs were separated on TLC before and after isolation by LH-60 chromatography. PL
phosphorus was measured as indicated in Methods. Recoveries of applied lipid were: C;BLES, 98.5 6 1.5; H;BLES, 87.8 6 4.7; F;BLES, 85.9 6 6.4;
C;PL, 96.5 6 8.2; H;PL, 85.9 6 6.4; F;PL, 90.1 6 3.4 (n ¼ 3). Abbreviations: LPC, lysophosphatidylcholine; SM, sphingomyelin; PC, phos-
phatidylcholine; PE, phosphatidylethanolamine; LPG, lysophosphatidylglycerol; LBPA, lyso-bis-phosphatidic acid.
*p , 0.05; **p , 0.01.
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dried and resuspended in working buffer, and surface activity
was studied in the CBT.
Initial ﬁlm formation (Fig. 3) was slightly retarded by
addition of control or oxidized PL to BLES, but only a few
surfactant preparations (BLES:F;AAPG, BLES:F;AAPC,
and BLES:H;POPG) displayed adsorption times signiﬁ-
cantly greater than those of their respective controls. Addi-
tion of either control or oxidized PL disturbed gmin compared
to BLES by around 8–10 mN/m (Fig. 4). However, BLES:
C;PL versus BLES:H;/F;PL did not show statistical
differences. It should be recognized that the observed in-
creases in gmin represent major decreases in surface activity
during surface area reduction. It is possible, therefore, that
smaller additions could show differences between control
and oxidized lipids. The percent of surface area reduction
necessary to achieve gmins ;2 mN/m from equilibrium was
also substantially affected by addition of either control or
oxidized PL, and in this case oxidized PL had a greater
effect. As a result, all mixtures BLES:H;/F;PL (except
BLES:H;/F;PLPC) reached signiﬁcance levels ( p, 0.05)
when compared with their matching BLES:C;PL (Fig. 5).
The gmaxs values, on the other hand, remained relatively
stable (,30 mN/m) for all the samples studied (Fig. 4).
SP-B analysis
The lack of substantial differences between the effects of
oxidized and control PL on BLES surfactant biophysical ac-
tivity prompted further examination of the effects of oxi-
dation on the surfactant low-molecular-weight hydrophobic
proteins. Fig. 6, A–C, shows a representative Coomassie
blue-stained gel, a representative western blot analysis, and
SP-B ELISA values for control and oxidized BLES as well
as for the proteins isolated from C;BLES, H;BLES, and
F;BLES. Equal amounts of protein as estimated by PL phos-
phorus for each surfactant sample (C;BLES, H;BLES, and
F;BLES) and as detected by Lowry for the isolated pro-
teins, were applied in each assay. The gel reveals that the
oxidized SP-B band has decreased reactivity with Coomassie
Blue stain, and this was more evident for Fenton-reacted
BLES and for the post-Fenton isolated SP-B (Fig. 6 A). SP-B
western blotting analysis (Fig. 6 B) demonstrated reduced
chemiluminescence reactivity with the oxidized surfactant
samples. The reduction of the signal was more evident for
F;SP-B. The ELISA values for SP-B (Fig. 6 C) conﬁrmed
the western blot ﬁndings for oxidized BLES and for isolated
SP-B. The ELISA values not only quantitate the western blot
results but test for potential differences due to alterations in
molecular size arising from SP-B fragmentation.
FIGURE 2 Protein carbonyl derivatives. Protein carbonyl levels were
determined by ELISA, using the Zentech PC Test Kit (Zenith Technology).
BLES values are expressed per mg BLES protein, where BLES contains 2%
protein w/w. SP-B and SP-C values refer to isolated protein. Comparisons
between two groups were made using paired Student t-test. a, p , 0.05
(control versus treated); b, p , 0.05 (H; versus F;).
FIGURE 3 Effects of addition of oxidized PL to BLES on the initial ﬁlm
formation. Horizontal bar graph representing the time required for the ﬁlms
to achieve equilibrium surface tension. Control or oxidized POPG, POPC,
PLPC, PLPG, AAPC, or AAPG were added to 50 mg/ml of BLES at 20%
w/w relative to surfactant PL. All measurements were performed in triplicate
at 37C. Comparisons among the samples were conducted by ANOVA fol-
lowed by Bonferroni and Tukey post-hoc tests. (*, p , 0.05 of appropriate
controls).
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SP-C analysis
Fig. 7 shows Coomassie blue (A), silver-stained gels (B), and
western blots (C) for control and oxidized BLES as well as
for the SP-C isolated from BLES, H;BLES, and F;BLES.
Equal amounts of protein as detected by Lowry were applied
per lane. Because of the high concentration of PL in BLES or
oxidized BLES, the amount of SP-C that could be detected
by Coomassie blue was impaired and the protein was hardly
visible. However the analysis of isolated SP-C shows that
after oxidation, the ;4-kDa band corresponding to this pro-
tein has decreased reactivity with Coomassie blue stain, and
this was more evident for isolated F;SP-C (Fig. 7 A). When
the same gel was developed with silver stain (Fig. 7 B), a
faint band corresponding to SP-C monomer was observed
with C;BLES (black arrow), but no corresponding bands
were visible with either H;BLES or F;BLES. In addition,
it was noted that SP-C from control BLES displayed lower
silver stain reactivity than with Coomassie blue. Further-
more, it was observed that the isolated oxidized SP-Cs show
higher degrees of polymerization with bands of molecular
weight of ;7 and 34 kDa appearing for H;SP-C, and for
F;SP-C bands of ;7, 55, 78, and 210 kDa. In addition, the
band for SP-C isolated from F;BLES corresponding to
native SP-C (black arrow at;4 kDa) displayed more intense
silver staining than the SP-C from C;BLES. SP-C western
blotting analysis (Fig. 7 C) demonstrated reduced chemilu-
minescence reactivity in the oxidized surfactant samples.
The reduction in the signal was more evident for F;BLES,
H;SP-C, and F;SP-C.
SP-C palmitoylation was estimated using reaction with [14C]
iodoacetamide (32,33). Fig. 8 is a representative autoradio-
gram of 14C-labeled SP-Cs obtained from BLES, H;BLES,
and F;BLES, as well as isolated C;SP-C, H;SP-C, and
F;SP-C. After the reacted samples were separated by Tricine-
SDS-PAGE and transfered to nitrocellulose, a [14C] SP-C-
labeled band corresponding to palmitoylated SP-C was
detected. Control reactions with 500 ng of isolated bovine
SP-C incubated without TEA are included to conﬁrm spec-
iﬁcity of the coupling reaction.
Fig. 8 B is a bar graph summarizing the quantitation of
[14C] SP-C bands with the software QuantiScan for Win-
dows, BIOSOFT 99. The autoradiography detected an;3.7-
kDa band corresponding to mature dipalmitoylated SP-C and
a smaller band, presumably corresponding to SP-C dimers,
was also observed with the isolated C;SP-C and H;SP-C.
Decreases in intensity of the bands due to reduced 14C in-
corporation were noticed for the oxidized samples indicating
loss of SP-C palmitoylation (Fig. 8, A and B). Depalmitoy-
lation of SP-C was greater with the Fenton reaction. These
results are in agreement with those found by silver stain
showing polymerization of SP-C since it has been reported
that in vitro removal of palmitic acid from SP-C leads to
destabilization of the protein and favors an increased rate of
polymerization (11,35).
Effects of free radical exposure on
surfactant function
The relative contributions of oxidized surfactant proteins
SP-B and/or SP-C, and oxidized PL, to surfactant function
impairment were studied with the CBT. Because of the large
number of samples analyzed, not all of the surface activity
results will be presented.
Total adsorption times to geq for C;BLES, H;BLES,
and F;BLES (before chromatographic isolation of PL and
FIGURE 4 Effects of addition of oxidized PL to BLES. Minimum (d) and
maximum (s) gs reached by the samples during the 21st dynamic cycling.
Samples are the same as in Fig. 3. All measurements were performed in
triplicate at 37C. Comparisons among the samples were conducted by
ANOVA followed by Bonferroni and Tukey post-hoc tests (*, p , 0.05 of
appropriate controls).
FIGURE 5 Effect of addition of oxidized PL to BLES, surface area
reduction. The bar graph depicts the percentage of surface area compression
required for the ﬁlms to attain a minimum surface tension near 0 from 20
mN/m during the 21st dynamic cycling. Samples are the same as in Fig. 3.
Extrapolated compressions of .100% were estimated for those ﬁlms that
could not attain low minima during compression. Comparisons among the
samples were conducted using Tukey’s studentized range (highly signiﬁcant
difference) test. Letters A–D represent comparisons among samples within a
cycle. Means with the same letter are not signiﬁcantly different for p, 0.05.
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proteins) and for the reconstituted samples studied are
illustrated in Fig. 9. Oxidation by exposure to either of the
two free radical systems resulted in retardation of initial ﬁlm
formation such that times to attain equilibrium increased
from ,5 min (C;BLES) to 20 min (H;BLES) and 40
min (F;BLES). In agreement with previous studies (3,8,32),
pure PL samples showed very slow adsorption. The ﬁlms
remained at 35–45 mN/m after 3 h and were not different
from H;PL or F;PL (data not shown). The reconstituted
surfactant containing PL:SP-B/SP-C adsorbs at a similar time
to C;BLES; likewise, the reconstituted samples containing
all of the oxidized components or with both surfactant pro-
teins oxidized paralleled the behavior of the parent surfac-
tants H;BLES and F;BLES. Samples containing oxidized
PL with nonoxidized proteins (H;PL:SP-B/SP-C, F;PL:
SP-B/SP-C) also generated retarded adsorption times, but the
effects were not as pronounced as with the oxidized proteins.
When both oxidized proteins were present, the initial ﬁlm
formation was greatly impaired.
Fig. 10 compares the effect of SP-B or SP-C oxidation on
initial ﬁlm formation. The presence of control SP-B or con-
trol SP-C alone or in combination was effective in promoting
PL adsorption at the interface; adsorption times are indistin-
guishable from BLES (2.146 0.31 min). When isolated SP-
B from oxidized BLES, either F;SP-B or H;SP-B was
present, addition of control SP-C did not improve this func-
tion. However, SP-B activity seems to prevail over oxidized
SP-C, the samples PL:SP-B/H;SP-C and PL:SP-B/F;SP-C
achieve geq in 6 and 8 min, correspondingly, in opposition
to PL:H;SP-C and PL:F;SP-C that adsorbed in 11 and
14 min, respectively, although these differences were not sta-
tistically signiﬁcant. However, replacing H;SP-B or F;SP-
B with control SP-B in the presence of the corresponding
oxidized SP-C resulted in a signiﬁcant reduction in adsorp-
tion time.
Dynamic cycling of adsorbed H;/F;BLES ﬁlms resulted
in considerably altered compression/expansion isotherms
compared to C;BLES. Initial isotherms for the adsorbed
oxidized surfactants began from near 2–3 mN/m above geq
(23 mN/m), the ﬁlms collapsed near geq, and during ﬁlm
expansion, gmaxs rose above equilibrium such that the 21st
compression cycle began at;40 mN/m for H-reacted and at
.50 mN/m for F-reacted surfactant. As reported previously
(3,29), lipid mixtures in the absence of proteins needed large
compression ratios (.100% surface area reduction) and only
achieved gmins of ;18–20 mN/m with gmaxs ;50 mN/m
(data not shown).
Figs. 11 and 12 represent the gmins (solid circles) and
gmaxs (open circles) attained by the studied samples during
the 21st dynamic cycle. PL:SP-B and PL:SP-B/SP-C achieved
gmin of,5 mN/m, comparable to C;BLES; conversely, the
samples reconstituted with all of the oxidized components or
FIGURE 6 SP-B analysis. (A) Representative Coomas-
sie blue stained gel, (B) representative western blot anal-
ysis, and (C) summary of SP-B ELISA values for control
and oxidized BLES, as well as for the isolated proteins from
BLES, H;BLES, and F;BLES. A total of 2 mg of protein
as detected by Lowry were applied to each lane, as described
in Experimental Procedures. Comparisons between two
groups were made using paired Student t-test (*, p, 0.05;
**, p , 0.01).
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both surfactant proteins oxidized (PL:H;SP-B/H;SP-C
and PL:F;SP-B/F;SP-C) matched the elevated gmins of
H;BLES and F;BLES. Mixtures containing oxidized PL
but ‘‘good’’ proteins suffered modest elevations in gmin.
When oxidized SP-B and SP-C were present, the ﬁlms were
not able to attain gmin ,12 mN/m (Figs. 11 and 12). The
most affected samples were those reconstituted with oxi-
dized proteins isolated from F;BLES. Samples containing
PL:SP-B were almost as effective as BLES (Figs. 11 and 12).
Replacing control SP-B with H;SP-B or F;SP-B elevated
both gmin and gmax, and adding control SP-C had no effect.
Samples containing PL:SP-C showed elevated gmins which
increased with H;SP-C or F;SP-C. In each case, addition
of control SP-B led to an improvement, which in the case
of F;SP-C was signiﬁcant. In addition, replacing H; or
F;SP-B where both proteins were oxidized led to a signif-
icant improvement. Thus, similar to the initial ﬁlm formation
studies, SP-B activity seems to prevail over oxidized SP-C.
However, the addition of ‘‘good’’ SP-C to surfactants con-
taining oxidized SP-B could not rescue this function. These
studies indicate that oxidizing either of the hydrophobic sur-
factant proteins leads to increased compressibility, but SP-B
oxidation was more deleterious than SP-C oxidation.
Oxidation also affected BLES respreading. Whereas oxi-
dized PL did not modify the gmaxs (.30 mN/m, Fig. 11)
reached during ﬁlm expansion, this parameter was signiﬁ-
cantly altered by the presence of oxidized proteins. The
highest gmaxs were observed in samples reconstituted with
oxidized SP-C and nonoxidized PL, reaching values .50
mN/m (Fig. 12). When SP-B isolated from BLES control
was added to these samples, a reduction of 10 mN/m was
recorded. However the addition of ‘‘good’’ SP-C to samples
containing oxidized SP-B did not show improvement.
In our experience, the percent surface area reduction nec-
essary to achieve gmins near zero mN/m is the most sensitive
indication of good surfactant function. Oxidized BLES
required a higher percent compression compared to BLES
control (Fig. 13). When either PL or surfactant proteins were
oxidized, the ﬁlms required surface area reductions .50%.
The highest surface area reductions were observed when all
three components were oxidized. In all cases, Fenton reac-
tion seemed to have a greater effect than hypochlorous reac-
tion, although the differences were not always statistically
signiﬁcant. The effects of SP-B oxidation versus SP-C oxi-
dation are summarized in Fig. 14. When SP-B or SP-C
isolated from BLES control was added to control PL, low gs
were achieved with a percent of compression ,30%. How-
ever, when either oxidized SP-B or oxidized SP-C was added,
larger percentage surface area reductions were required (60–
100%). Although functional SP-B activity seems to prevail
over oxidized SP-C, the addition of control SP-C to samples
containing oxidized SP-B was not as effective in counter-
acting the effects of oxidized SP-B.
FIGURE 7 SP-C analysis. (A) Representative Coomassie blue gel and (B)
representative silver-stained gel for control and oxidized BLES as well as for
the isolated SP-C from C;BLES, H;BLES, and F;BLES. A total of 2 mg
of protein as detected by Lowry was applied per lane. Procedures are described
in Experimental Procedures. The white arrows show the location of SP-B,
whereas the black arrows show the location of SP-C. (C) Representative
Western Blot conﬁrming qualitative alterations of SP-C in the oxidized
surfactants.
FIGURE 8 SP-C palmitoylation. (A) Representative autoradiography of
14C-labeled SP-Cs obtained from BLES, H;BLES, and F;BLES, as well
as isolated C;SP-C, H;SP-C, and F;SP-C. After the reacted samples were
separated by Tricine-SDS-PAGE and transferred to nitrocellulose, a [14C]
SP-C-labeled band corresponding to palmitoylated SP-C was detected at
3.7 kDa. (B) Bar graph summarizing the relative amount of mature SP-C
as determined by quantitation of [14C] SP-C bands with the software
QuantiScan for Windows, BIOSOFT 99. Comparisons between two groups
were made using paired Student t-test (*, p , 0.05; **, p , 0.01).
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DISCUSSION
In vivo, pulmonary surfactant is directly exposed to oxida-
tive air pollutants in the alveolar space. In the subphase be-
tween lung epithelial cells and the monolayer, surfactant is
exposed to ROS produced by activated leukocytes and mac-
rophages (22). ROS likely plays an important role in the
pathogenesis of pulmonary diseases in adults (2,36) and
preterm infants (37).
Activated neutrophils recruited into the alveolar space
generate HOCl/OCl (2,22,38). Surfactant molecules may
be exposed also to ongoing Fenton chemistry. Pro-oxidant
iron is present in normal human pulmonary epithelial lining
ﬂuid and was found increased in ARDS patients (39).
Catalysis by Fe12 in the generation of ROS through redox
cycling has been well documented in biological systems, in
tissue injuries, and in many pathological conditions (22,40).
In this study, we incubated BLES for 24 h with either
hypochlorous acid or the Fenton reagents at concentrations
considered in the pathophysiological range ((17,20,41), see
Rodrı´guez-Capote et al. (22) for review). These two oxidizing
systems produce different effects). Exposure to the Fenton
reaction results in greater production of conjugated dienes,
MDA and HNE, carbonyl derivatives, and protein modiﬁ-
cations than exposure to HOCl/OCl. These results are
relevant, since there is growing evidence that many in-
dividual etiologies of ARDS are associated with a disruption
of normal iron metabolism in the lung (39,42).
The unfavorable changes in surface activity after exposure
of the surfactant samples to ROS suggested underlying mech-
anisms involving chemical reactions that can modify both
PL and surfactant proteins and their interactions, thereby
disturbing the balance and structural arrangements of the sur-
factant phospholipid-protein complexes and leading to poor
surface activity. The TLC analysis showed that oxidized BLES
and the PL fractions isolated from these oxidized surfactants
contain signiﬁcant decreases in total recoverable PC and PG,
the most abundant PLs in surfactant, with consequent in-
creases in LPC and, in the case of H; and F;BLES, LPG. It
is known that peroxidation of polyunsaturated PL acyl groups
in vivo is accompanied by further chemical modiﬁcations
leading to the generation of lysoPL via a phospholipase A2-
like mechanism (19,43) with a complementary decrease in
the fractional content of parental PL. LysoPL are amphi-
pathic molecules possessing ‘‘detergent-like’’ properties that
can alter cellular membranes and previous reports from our
laboratory and others have shown that LPC inhibits surfac-
tant activity (44–46). Likewise, the decrease in unsaturated
species could also contribute to reduced surface activity
(14,47). Unsaturated PGs appear to perform important func-
tions in adsorption, spreading, and respreading of the ﬁlm,
FIGURE 10 Reconstitution studies. Effect of SP-B versus SP-C oxidation
on surfactant adsorption. Horizontal bar graph illustrating the total adsorp-
tion times for controls (PL:SP-B, PL:SP-C and PL:SP-B:SP:C); samples con-
taining oxidized SP-B (PL:H;SP-B, PL:F;SP-B, PL:H;SP-B:SP-C,
PL:F;SP-B:SP-C); and samples containing oxidized SP-C, (PL:H;SP-C,
PL:F;SP-C, PL:SP-B:H;SP-C, and PL:SP-B:F;SP-C). Samples are as in
Fig. 9. Data are from at least three separate experimental samples. Compar-
isons among the samples were conducted by ANOVA followed by Bonferroni
and Tukey post-hoc tests. Letters represent comparisons among samples.
Means with the same letter are not signiﬁcantly different for p , 0.05.
FIGURE 9 Reconstitution studies. Effect of PL oxidation versus protein
oxidation on surfactant adsorption. Horizontal bar graph illustrating the total
adsorption times for C;BLES, H;BLES and F;BLES before isolation and
the following reconstituted samples in working buffer; control (PL:SP-B:SP-
C), oxidized PL with nonoxidized proteins (H;PL:SP-B:SP-C and
F;PL:SP-B:SP-C), both oxidized proteins with control PL (PL:H;SP-B:
H;SP-C and PL:F;SP-B:F;SP-C) and all the constituents oxidized
(H;PL:H;SP-B:H;SP-C and F;PL:F;SP-B:F;SP-C). Samples contain
500 mg PL/ml. Data are from at least three separate experimental samples.
Comparisons among the samples were conducted using Tukey’s studentized
range test. Letters represent comparisons among samples within a cycle.
Means with the same letter are not signiﬁcantly different for p , 0.05.
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likely by interactions of this anionic PL with SP-B
((29,48,49); see Possmayer (3) and Hawgood et al. (10) for
review). Furthermore, decreases of PG and increases in
lysoPL have been reported in inﬂammation-related airways
disease ((50,51); see Lewis and Veldhuizen (2) and Gunther
et al. (15) for review). The accumulation of lipoperoxidation
subproducts such as aldehydes (MDA and HNE), free fatty
acids, and lysoPL, as well as a decrease in unsaturated
species may account in part for the reduced surface activity
of oxidized BLES reported in this study.
PL addition to BLES affected surface activity, and for
some surfactants the effects were greater when the PLs were
oxidized. However, in general, no major differences in sur-
face activity were found between BLES:C;PL and BLES:
H;/F;PL; only the percent of compression required to
reach gs near zero show statistical differences between the
groups. These results suggested that PL oxidation has minor
detrimental effects on surface activity. This prompted us to
examine in more detail the hypothesis that surfactant apo-
protein oxidation is more important for the surfactant dys-
function.
Protein aggregation or fragmentation can occur during oxi-
dation (52). However, although SP-B multimers have been
reported (10), we were not able to detect higher- or lower-
molecular-weight bands for SP-B in the gels by Coomassie
blue or silver stain. Overall, similar decreases in reactivity
were noted with BLES and with size-fractionated SP-B.
Some gels (e.g., Fig. 8 B) gave evidence for altered mi-
gration. With such gels, control BLES showed a diffuse
silver-stained band, likely due to the large amounts of lipid
and the highly hydrophobic nature of SP-B. H;BLES pres-
ents a similar, albeit diminished SP-B ‘‘shadow’’ with a
smaller, more intensely stained band. A smaller shadowed
band was observed with F;BLES. In addition, because the
amounts of protein applied were the same for each sample
examined, ELISA and western blot results (Fig. 6, B and C)
are consistent with the conclusion that oxidative modiﬁca-
tions of SP-B led to decreased recognition by the anti-SP-B
antibody. In each case, examination of isolated SP-B led to
results similar to those obtained with whole surfactant. In all
cases, SP-B structure/conformation was more affected by the
Fenton reaction. SP-B contains amphipathic helices with the
hydrophilic face containing a number of positively charged
amino acids and a hydrophobic face rich in the aliphatic
amino acids isoleucine, leucine, and valine (10). The am-
phipathic nature of SP-B allows the protein to interact with
both the polar headgroups and the acyl side chains of the
surfactant PL. Oxidized BLES shows increases in protein
carbonyls, signifying decreases in basic amino acids such as
His, Arg, and Lys (40,52), and consequently there are fewer
positive charges available for the protein to interact with the
PL. The loss of positive charges could contribute to the
FIGURE 11 Reconstitution studies. Effect of PL oxidation versus protein
oxidation on minimum and maximum gs. Minimum (d) and maximum (s)
gs reached by the samples during the 21st dynamic cycling. Samples are as
in Fig. 9. The data are the average of three separate experimental samples.
Comparisons among the samples were conducted by ANOVA followed by
Bonferroni and Tukey post-hoc tests. Letters a–f and A–G represent com-
parisons among samples in Figs 11 and 12. Means with the same letter are
not signiﬁcantly different for p , 0.05.
FIGURE 12 Reconstitution studies. Effects of SP-B versus SP-C oxida-
tion on minimum and maximum gs. Minimum (d) and maximum (s) gs
reached by the samples during the 21st dynamic cycling. Samples are as in
Fig. 10. The data are the average of three separate experimental samples.
Comparisons among the samples were conducted by ANOVA followed by
Bonferroni and Tukey post-hoc tests. Letters a–f and A–G represent com-
parisons among samples. Means with the same letter are not signiﬁcantly
different for p , 0.05.
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decrease in surface activity seen with SP-B isolated from
oxidized BLES. In support of this suggestion, surfactant
samples containing lipid and SP-B function less well in an
alkaline environment than at pH values approaching the
pKas of the basic amino acids (53,54).
SP-C contains two positively charged residues (Arg and
Lys) in the N-terminal region that are important for the bind-
ing of PL vesicles to the monolayer, a process that precedes
insertion of phospholipids into the monolayer (8,11). As
mentioned above, these two amino acids are susceptible to
forming protein carbonyls (52). Additional analysis of SP-C
conﬁrmed that this protein was further affected by the
exposure to oxidation. The SDS-PAGE gel developed with
silver stain shows appearance of higher-molecular-weight
bands for the SP-C isolated from the oxidized samples. This
may explain, in part, the decreased Coomasie blue staining
intensity for the 3.7-kDa bands corresponding to the di-
palmitoylated H;SP-C (Fig. 7, A and B). Interestingly,
although SP-C isolated from H;BLES and F;BLES shows
reduced staining with Coomassie blue, SP-C from F;BLES
was highly reactive to silver staining. The mechanisms re-
sponsible for silver staining are complex (55), but it is
evident from the gels that Fenton reaction increases rather
than decreases reactivity. In agreement with these ﬁndings,
oxidized SP-C portrayed lower levels of palmitoylation (Fig.
8). Palmitoylation of SP-C has been shown to be important
for the stability and compressibility of the surfactant ﬁlm as
well as for the formation of the surface associated lipid
reservoir (3,9,11). Under oxidative stress conditions, desta-
bilizing amino acid modiﬁcations and cleavage of the SP-C
two thioester-linked palmitoyl groups may be mediated by
ROS, such as hydrogen peroxide, superoxide anions, per-
oxynitrite, and hypochlorite released from inﬂammatory cells.
The loss of the palmitoyl groups and/or loss of the two pos-
itive charges provoked by oxidation may destabilize SP-C,
which can inﬂuence amyloid formation by facilitating a-helix
to b-sheet conversion, resulting in ﬁbril formation (11,35).
Whether the decreased SP-C activity documented here arises
from depalmitoylation or from amino acid modiﬁcations re-
sulting in oligomerization and decreased anti-SP-C antibody
recognition is not clear from the studies described here, and
awaits further investigation.
The mechanisms by which pulmonary surfactant functions
are not fully understood. Nevertheless it is clear that the
surfactant proteins SP-B and SP-C are essential for surfactant
function. In vitro experiments conducted with spread surfac-
tant monolayers suggested that these surfactant apoproteins
alter the PL packing, lowering the compressibility of the
monolayer. A key role of SP-B and SP-C is to alter the
collapse mechanism from fracture and vesicle formation to a
FIGURE 14 Reconstitution studies. Effect of SP-B and SP-C oxidation on
surface area reduction. The bar graph shows the percentage of surface area
reduction required for the ﬁlms to attain a minimum surface tension near 0
from 20 mN/m during the 21st dynamic cycling. Extrapolated compressions
of .100% were estimated for those ﬁlms that could not attain low minima
during compression. Samples are as in Fig. 10. The data are the average of
three separate experimental samples. Comparisons among the samples were
conducted using Tukey’s studentized range (highly signiﬁcant difference)
test. Letters A–E represent comparisons among samples within a cycle.
Means with the same letter are not signiﬁcantly different for p , 0.05.
FIGURE 13 Reconstitution studies. Effect of PL oxidation versus protein
oxidation on surface area reduction. The bar graph shows the percentage of
surface area reduction required for the ﬁlms to attain a minimum surface
tension near 0 from 20 mN/m during the 21st dynamic cycling. Extrapolated
compressions of.100% were estimated for those ﬁlms that could not attain
low minima during compression. Samples are as in Fig. 9. Data are the aver-
age of three independent experiments. Comparisons among the samples were
conducted using Tukey’s studentized range (highly signiﬁcant difference)
test. Letters A–E represent comparisons among samples within Figs 13 and
14. Means with the same letter are not signiﬁcantly different for p , 0.05.
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reversible folding that allows the ﬁlms to achieve low g
during surface area reduction while favoring respreadability
during surface area expansion (8,9,56). It is now believed
that in vivo a multilayer of lipid-protein structures underly-
ing the surface monolayer expands and contracts as material
leaves and reenters the monolayer during the respiratory cy-
cles, and that the surfactant proteins contribute to this be-
havior (56–59). When either oxidized SP-B or SP-C was
present, surface activity was greatly affected. These results
are in good overall agreement with previous studies dem-
onstrating that exposing surfactant or surfactant proteins to
reactive oxygen or nitrogen species results in reduced sur-
factant activity (18,24). Interesting results were obtained
when SP-B or SP-C isolated from BLES control was added
to samples reconstituted with control PL and the other pro-
tein oxidized. Addition of control SP-B to samples containing
oxidized SP-C resulted in a signiﬁcant improvement in
adsorption, g reduction properties, and respreading. In other
words, the activity of ‘‘good’’ SP-B seems to prevail over the
deleterious effects of oxidized SP-C. However, the presence
of ‘‘good’’ SP-C in samples containing oxidized SP-B could
not rescue the surface activity. In this regard, it should be
mentioned that addition of SP-A to H;BLES and F;BLES
results in a signiﬁcant recovery of surface activity (20). Based
on parallel studies, this SP-A-induced improvement is likely
dependent on the presence of SP-B (29).
These investigations demonstrated that ROS arising from
either hypochlorous acid or the Fenton reaction affected
pulmonary surfactant structure and function. Interestingly,
under the conditions employed, Fenton had a signiﬁcantly
greater effect on PL and surfactant protein chemistry than
hypochlorous acid. Differences in the effects on surfactant
function were less obvious. However F;reacted SP-B and/
or SP-C were less effective than H;reacted counterparts in
ﬁlm compressibility. This is the most sensitive and likely the
most critical parameter studied. Thus, we conclude that the
Fenton reaction affects both surfactant structure and function
to a greater extent than hypochlorous acid.
The fundamental importance of SP-B in pulmonary func-
tion in vivo is emphasized by the observation that infants
unable to produce SP-B due to mutations of the SP-B gene
develop lethal neonatal respiratory disease (60). Antibodies
to SP-B disrupt surfactant function in vivo (3,61). Targeted
disruption of the SP-B gene in mice results in respiratory
failure and death immediately after birth in the homozygous
SP-B-deﬁcient mice because of their inability to inﬂate their
lungs and establish respiration (61,62). Genetic curtailing of
SP-B production in adult mice induces lethal respiratory
distress associated with loss of function of the pulmonary
surfactant (62). Whereas SP-B deﬁciency results in an under-
standable phenotype, the lung diseases associated with het-
erozygous SP-C deﬁciency as well as the functions of SP-C
in vivo are not fully understood. Although no obvious ab-
normalities were identiﬁed in SP-C knockout mice at birth,
they showed signs of surfactant instability at low lung vol-
umes and in adulthood they developed pneumonia and em-
physema (61,63). SP-C alterations have been associated with
chronic lung diseases in humans (60,63). It is possible that
modiﬁcations of SP-C, whether genetic or secondary to oxi-
dative damage, are masked because the presence of SP-B
guarantees acceptable surfactant activity for the performance
of respiratory cycles. Consequently, SP-C alterations con-
tribute to chronic lung diseases only in an accumulative
manner, most likely through cell toxicity.
In summary, the results described in this article reveal that,
in addition to surfactant lipids, both SP-B and SP-C undergo
changes during oxidation that signiﬁcantly decrease their bio-
physical properties. The surface activity impairment found in
the reconstituted mixtures suggests that protein oxidation is
the major cause of the impaired activity of oxidized sur-
factants, whereas PL oxidation has a lesser effect. Although
oxidation to either SP-B or SP-C can hamper surfactant func-
tion, nonoxidized SP-B can improve samples containing oxi-
dized SP-C. Damage to surfactant hydrophobic proteins may
play an important role in the surfactant dysfunction that
arises during lung oxidative stress-related disorders such as
ARDS, cystic ﬁbrosis, and asthma.
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